Literature DB >> 24316641

Rational drug repositioning by medical genetics.

Zhong-Yi Wang1, Hong-Yu Zhang.   

Abstract

Mesh：

Year:  2013        PMID： 24316641     DOI： 10.1038/nbt.2758

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  13 in total

1.  Can medical genetics and evolutionary biology inspire drug target identification?

Authors:  Zhong-Yi Wang; Liang-Yu Fu; Hong-Yu Zhang
Journal:  Trends Mol Med       Date:  2011-12-13       Impact factor: 11.951

2.  Use of genome-wide association studies for drug repositioning.

Authors:  Philippe Sanseau; Pankaj Agarwal; Michael R Barnes; Tomi Pastinen; J Brent Richards; Lon R Cardon; Vincent Mooser
Journal:  Nat Biotechnol       Date:  2012-04-10       Impact factor: 54.908

Review 3.  Literature mining, ontologies and information visualization for drug repurposing.

Authors:  Christos Andronis; Anuj Sharma; Vassilis Virvilis; Spyros Deftereos; Aris Persidis
Journal:  Brief Bioinform       Date:  2011-06-28       Impact factor: 11.622

4.  Adverse cardiac effects of salt with fludrocortisone in hypertension.

Authors:  P O Lim; C A Farquharson; P Shiels; R T Jung; A D Struthers; T M MacDonald
Journal:  Hypertension       Date:  2001-03       Impact factor: 10.190

5.  Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist.

Authors:  A J van der Lely; R K Hutson; P J Trainer; G M Besser; A L Barkan; L Katznelson; A Klibanski; V Herman-Bonert; S Melmed; M L Vance; P U Freda; P M Stewart; K E Friend; D R Clemmons; G Johannsson; S Stavrou; D M Cook; L S Phillips; C J Strasburger; S Hackett; K A Zib; R J Davis; J A Scarlett; M O Thorner
Journal:  Lancet       Date:  2001-11-24       Impact factor: 79.321

6.  Prospective study of sex hormone levels and risk of prostate cancer.

Authors:  P H Gann; C H Hennekens; J Ma; C Longcope; M J Stampfer
Journal:  J Natl Cancer Inst       Date:  1996-08-21       Impact factor: 13.506

Review 7.  Drospirenone, a new progestogen, for postmenopausal women with hypertension.

Authors:  Madhavi Mallareddy; Vladimir Hanes; William B White
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 8.  Human monogenic disorders - a source of novel drug targets.

Authors:  Ryan R Brinkman; Marie-Pierre Dubé; Guy A Rouleau; Andrew C Orr; Mark E Samuels
Journal:  Nat Rev Genet       Date:  2006-04       Impact factor: 53.242

9.  Factitious Bartter's syndrome induced by surreptitious intake of furosemide.

Authors:  K Sekine; I Kojima; T Fujita; K Uchino; S Isozaki; E Ogata
Journal:  Endocrinol Jpn       Date:  1982-10

10.  Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes.

Authors:  Christopher E Lowe; Jason D Cooper; Todd Brusko; Neil M Walker; Deborah J Smyth; Rebecca Bailey; Kirsi Bourget; Vincent Plagnol; Sarah Field; Mark Atkinson; David G Clayton; Linda S Wicker; John A Todd
Journal:  Nat Genet       Date:  2007-08-05       Impact factor: 38.330
View more
  43 in total

1.  Reply to Rational drug repositioning by medical genetics.

Authors:  Philippe Sanseau; Pankaj Agarwal; Michael R Barnes; Tomi Pastinen; J Brent Richards; Lon R Cardon; Vincent Mooser
Journal:  Nat Biotechnol       Date:  2013-12       Impact factor: 54.908

2.  Drug repositioning for prostate cancer: using a data-driven approach to gain new insights.

Authors:  QuanQiu Wang; Rong Xu
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

3.  The support of human genetic evidence for approved drug indications.

Authors:  Matthew R Nelson; Hannah Tipney; Jeffery L Painter; Judong Shen; Paola Nicoletti; Yufeng Shen; Aris Floratos; Pak Chung Sham; Mulin Jun Li; Junwen Wang; Lon R Cardon; John C Whittaker; Philippe Sanseau
Journal:  Nat Genet       Date:  2015-06-29       Impact factor: 38.330

4.  Opportunities for drug repositioning from phenome-wide association studies.

Authors:  Majid Rastegar-Mojarad; Zhan Ye; Jill M Kolesar; Scott J Hebbring; Simon M Lin
Journal:  Nat Biotechnol       Date:  2015-04       Impact factor: 54.908

5.  Molecularly and clinically related drugs and diseases are enriched in phenotypically similar drug-disease pairs.

Authors:  Ingo Vogt; Jeanette Prinz; Mónica Campillos
Journal:  Genome Med       Date:  2014-08-17       Impact factor: 11.117

6.  Phenome-based gene discovery provides information about Parkinson's disease drug targets.

Authors:  Yang Chen; Rong Xu
Journal:  BMC Genomics       Date:  2016-08-31       Impact factor: 3.969

7.  Revisiting Antipsychotic Drug Actions Through Gene Networks Associated With Schizophrenia.

Authors:  Karolina Kauppi; Sara Brin Rosenthal; Min-Tzu Lo; Nilotpal Sanyal; Mian Jiang; Ruben Abagyan; Linda K McEvoy; Ole A Andreassen; Chi-Hua Chen
Journal:  Am J Psychiatry       Date:  2018-03-02       Impact factor: 18.112

8.  DR2DI: a powerful computational tool for predicting novel drug-disease associations.

Authors:  Lu Lu; Hua Yu
Journal:  J Comput Aided Mol Des       Date:  2018-04-23       Impact factor: 3.686

9.  Combining Human Disease Genetics and Mouse Model Phenotypes towards Drug Repositioning for Parkinson's disease.

Authors:  Yang Chen; Xiaoshu Cai; Rong Xu
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

10.  Endocrine-disrupting chemicals in coastal lagoons of the Po River delta: sediment contamination, bioaccumulation and effects on Manila clams.

Authors:  Nadia Casatta; Fabrizio Stefani; Fiorenzo Pozzoni; Licia Guzzella; Laura Marziali; Giuseppe Mascolo; Luigi Viganò
Journal:  Environ Sci Pollut Res Int       Date:  2015-10-28       Impact factor: 4.223
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.